Published by
@ShahidNShah
@ShahidNShah
0-50Healthcare
100 Rodolphe Street, Durham, North Carolina, 27712, United States
Banyan Biomarkers was founded by scientists from the University of Florida McKnight Brain Institute that came together to address the challenges in diagnosing traumatic brain injury (TBI), also known as concussion. Traumatic brain injury has been termed an ‘invisible injury’ because the patient may look fine but symptoms like headache, confusion, and sensitivity to light can be persistent. This unmet medical need has been the driving force to research and develop a blood based biomarker test for brain injury. With support from the US Department of Defense and researcher partners all over the world, the company has made significant steps to validate the use of Ubiquitin C- terminal Hydrolase-L1 (UCH-L1) and Glial Fibrillary Acidic Protein (GFAP) to rule out the need for a computed tomography (CT) scan in adults that present with a suspected head injury.
The Banyan BTITM is an in vitro diagnostic assay that uses the chemiluminescent enzyme-linked immunosorbent assay (ELISA) technique to provide a semi-quantitative measurement of the concentrations of …
Posted FDA Breakthrough Device Designation
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 21, 2024 at 12:56pm